ATE119881T1 - 3-(2-(dimethylamino)ethyl>-n-methyl-1h-indol-5- methansulfonamid sulfat (2:1). - Google Patents
3-(2-(dimethylamino)ethyl>-n-methyl-1h-indol-5- methansulfonamid sulfat (2:1).Info
- Publication number
- ATE119881T1 ATE119881T1 AT91311583T AT91311583T ATE119881T1 AT E119881 T1 ATE119881 T1 AT E119881T1 AT 91311583 T AT91311583 T AT 91311583T AT 91311583 T AT91311583 T AT 91311583T AT E119881 T1 ATE119881 T1 AT E119881T1
- Authority
- AT
- Austria
- Prior art keywords
- indole
- dimethylamino
- ethyl
- methyl
- methanesulfonamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909026998A GB9026998D0 (en) | 1990-12-12 | 1990-12-12 | Medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE119881T1 true ATE119881T1 (de) | 1995-04-15 |
Family
ID=10686904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91311583T ATE119881T1 (de) | 1990-12-12 | 1991-12-12 | 3-(2-(dimethylamino)ethyl>-n-methyl-1h-indol-5- methansulfonamid sulfat (2:1). |
Country Status (36)
Country | Link |
---|---|
US (2) | US5554639A (de) |
EP (1) | EP0490689B1 (de) |
JP (1) | JP2994037B2 (de) |
KR (1) | KR100211479B1 (de) |
CN (2) | CN1030890C (de) |
AP (1) | AP230A (de) |
AT (1) | ATE119881T1 (de) |
AU (1) | AU650706B2 (de) |
BE (1) | BE1005085A3 (de) |
CA (1) | CA2098302C (de) |
CH (1) | CH684192A5 (de) |
CY (1) | CY2005A (de) |
CZ (1) | CZ281931B6 (de) |
DE (1) | DE69108200T2 (de) |
DK (1) | DK0490689T3 (de) |
EG (1) | EG20219A (de) |
ES (1) | ES2069836T3 (de) |
FR (1) | FR2670487B1 (de) |
GB (2) | GB9026998D0 (de) |
GR (1) | GR3015430T3 (de) |
HK (1) | HK82697A (de) |
HU (1) | HU211937A9 (de) |
IE (1) | IE62894B1 (de) |
IL (1) | IL100330A (de) |
IS (1) | IS1706B (de) |
IT (1) | IT1252868B (de) |
MX (1) | MX9102501A (de) |
MY (1) | MY109265A (de) |
NL (1) | NL9102071A (de) |
NZ (1) | NZ240942A (de) |
PT (1) | PT99757B (de) |
RU (1) | RU2108328C1 (de) |
TW (2) | TW205035B (de) |
WO (1) | WO1992010477A1 (de) |
YU (1) | YU48926B (de) |
ZA (1) | ZA919750B (de) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA27908C2 (uk) * | 1992-06-05 | 2000-10-16 | Мерк Шарп Енд Дом Лімітед | Сульфатна сіль n,n-диметил-2-[5-(1,2,4-триазол-1ілметил)-1н-індол-3-іл]етиламіну та/або її сольвати, фармацевтична композиція на її основі, спосіб одержання фармацевтичної композиції і спосіб лікування |
FR2749846B1 (fr) * | 1996-06-17 | 1998-09-11 | Pf Medicament | Sel de methanesulfonate d'une arylpiperazine derivee de tryptamine et ses solvates pour usage pharmaceutique |
US8022095B2 (en) * | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US6106837A (en) * | 1997-05-15 | 2000-08-22 | Hirsch; Alan R. | Method of treating headaches, and article of manufacture therefor |
US6066092A (en) * | 1997-11-06 | 2000-05-23 | Cady; Roger K. | Preemptive prophylaxis of migraine device and method |
US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
US6187790B1 (en) | 1999-03-04 | 2001-02-13 | Neal R. Cutler | Use of cilostazol for treatment of sexual dysfunction |
US6132757A (en) | 1998-05-01 | 2000-10-17 | Neal R. Cutler | Treatment of sexual dysfunction in certain patient groups |
US6426084B1 (en) * | 2000-06-19 | 2002-07-30 | Neal R. Cutler | Treatment of sexual dysfunction in certain patient groups |
GB9926250D0 (en) * | 1999-11-06 | 2000-01-12 | Knoll Ag | Chemical process |
US6610271B2 (en) * | 2000-05-10 | 2003-08-26 | University Of Kentucky Research Foundation | System and method for intranasal administration of lorazepam |
US20040115133A1 (en) * | 2000-05-10 | 2004-06-17 | Wermeling Daniel P. | Intranasal opioid compositions |
US6451813B1 (en) | 2001-01-26 | 2002-09-17 | R. T. Alamo Ventures I, Llc | Treatment of gastroparesis in certain patient groups |
US6562838B2 (en) * | 2001-01-26 | 2003-05-13 | R. T. Alamo Ventures I, L.L.C. | Treatment of cardiovascular disease with quinolinone enantiomers |
US6458804B1 (en) | 2001-01-26 | 2002-10-01 | R.T. Alamo Venturesi, Llc | Methods for the treatment of central nervous system disorders in certain patient groups |
US20040176359A1 (en) * | 2001-02-20 | 2004-09-09 | University Of Kentucky Research Foundation | Intranasal Benzodiazepine compositions |
US20030096748A1 (en) * | 2001-06-04 | 2003-05-22 | The Regents Of The University Of Michigan | Methods and compositions for the treatment of diseases associated with signal transduction aberrations |
US8329734B2 (en) * | 2009-07-27 | 2012-12-11 | Afgin Pharma Llc | Topical therapy for migraine |
US20030013753A1 (en) * | 2001-06-05 | 2003-01-16 | Ronald Aung-Din | Transdermal migraine therapy |
US7041677B2 (en) * | 2002-03-01 | 2006-05-09 | R.T. Alamo Ventures I, Llc | Use of monochloroflosequinan in the treatment of sexual dysfunction |
US7208628B2 (en) * | 2002-05-13 | 2007-04-24 | Kansas State University Research Foundation | Compositions and methods for the treatment of hepatitis C virus infection |
US7074893B2 (en) * | 2002-06-03 | 2006-07-11 | Regents Of The University Of Michigan | Methods and compositions for the treatment of diseases associated with signal transduction aberrations |
US20040068000A1 (en) * | 2002-10-02 | 2004-04-08 | Mintong Guo | Compression coated tablets |
ATE546134T1 (de) * | 2002-12-26 | 2012-03-15 | Pozen Inc | Mehrschichtige dosierformen enthaltend naproxen und triptane |
US20080213363A1 (en) * | 2003-01-23 | 2008-09-04 | Singh Nikhilesh N | Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa |
WO2004076403A1 (en) * | 2003-02-24 | 2004-09-10 | Transform Pharmaceuticals, Inc. | Sumatriptan crystalline forms, pharmaceutical compositions and methods |
CA2529528A1 (en) | 2003-06-20 | 2004-12-29 | Ronald Aung-Din | Topical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions |
US20050089558A1 (en) * | 2003-10-28 | 2005-04-28 | Alamo Pharmaceuticals, Llc | Compositions and methods for the co-formulation and administration of tramadol and propoxyphene |
WO2005119607A2 (en) * | 2004-06-03 | 2005-12-15 | Tyfone, Inc. | System and method for securing financial transactions |
CA2569964A1 (en) * | 2004-06-10 | 2005-12-29 | Duramed Pharmaceuticals, Inc. | Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
JP2008545650A (ja) | 2005-05-20 | 2008-12-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | スルファミド誘導体の製造方法 |
WO2007070504A2 (en) * | 2005-12-13 | 2007-06-21 | Morton Grove Pharmaceuticals, Inc. | Stable and palatable oral liquid sumatriptan compositions |
US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
US8492431B2 (en) | 2005-12-19 | 2013-07-23 | Janssen Pharmaceutica, N.V. | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
US20070191461A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of benzo-heteroaryl sulfamide derivatives for the treatment of migraine |
TW200812573A (en) | 2006-05-19 | 2008-03-16 | Janssen Pharmaceutica Nv | Co-therapy for the treatment of epilepsy and related disorders |
EP2124556B1 (de) | 2006-10-09 | 2014-09-03 | Charleston Laboratories, Inc. | Pharmazeutische zusammensetzungen |
AU2007310949A1 (en) * | 2006-10-19 | 2008-04-24 | Auspex Pharmaceuticals, Inc. | Substituted indoles |
US20080275030A1 (en) * | 2007-01-19 | 2008-11-06 | Sveinbjorn Gizurarson | Methods and Compositions for the Delivery of a Therapeutic Agent |
GB2448183A (en) * | 2007-04-05 | 2008-10-08 | Optinose As | Nasal powder delivery device |
EP2240022B1 (de) | 2008-01-09 | 2016-12-28 | Charleston Laboratories, Inc. | Oxycodone und Promethazine enthaltende zweischichtige Tabletten |
US20090252791A1 (en) * | 2008-04-02 | 2009-10-08 | Venkata Nookaraju Sreedharala | Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug |
CN102046621B (zh) | 2008-05-27 | 2014-11-12 | 生物区科学管理控股有限公司 | 抗病毒盐 |
AU2009260166B2 (en) * | 2008-06-20 | 2014-10-09 | Alphapharm Pty Ltd | Pharmaceutical formulation |
MX2011000090A (es) | 2008-06-23 | 2011-03-02 | Janssen Pharmaceutica Nv | Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo[1,4]diox in-2-ilmetil)sulfamida. |
CA2729346A1 (en) * | 2008-06-30 | 2010-01-14 | Afgin Pharma, Llc | Topical regional neuro-affective therapy |
US8815939B2 (en) | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
EP3311667A1 (de) | 2009-07-08 | 2018-04-25 | Charleston Laboratories, Inc. | Pharmazeutische zusammensetzungen |
US11337962B2 (en) | 2009-09-25 | 2022-05-24 | Upsher-Smith Laboratories, Llc | Formulations comprising triptan compounds |
NZ599344A (en) * | 2009-09-25 | 2015-02-27 | Reddy’S Lab Ltd Dr | Formulations comprising triptan compounds |
AU2016226267A1 (en) | 2015-03-02 | 2017-09-28 | Afgin Pharma, Llc | Topical regional neuro-affective therapy with cannabinoids |
US10383816B2 (en) | 2015-03-02 | 2019-08-20 | Afgin Pharma, Llc | Topical regional neuro-affective therapy with cannabinoid combination products |
JP6897971B2 (ja) | 2015-05-15 | 2021-07-07 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 関節炎を処置するための、方法および組成物 |
CA3055170A1 (en) | 2016-03-04 | 2017-09-08 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
US20180049994A1 (en) | 2016-08-16 | 2018-02-22 | Afgin Pharma, Llc | Topical regional neuro-affective therapy with caryophyllene |
US10723718B2 (en) | 2017-11-07 | 2020-07-28 | The Regents Of The University Of Michigan | Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use |
WO2020049523A1 (en) | 2018-09-07 | 2020-03-12 | Upsher-Smith Laboratories, Llc | Methods of treating migraine |
US11364225B2 (en) * | 2019-08-21 | 2022-06-21 | Bn Intellectual Properties, Inc. | Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same |
BR112022016790A2 (pt) * | 2020-02-27 | 2022-11-08 | Biohaven Pharm Holding Co Ltd | Forma de dosagem oral de dispersão rápida de rimegepant |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2162522B (en) * | 1984-08-01 | 1988-02-24 | Glaxo Group Ltd | An indole derivative |
GB8615599D0 (en) * | 1986-06-26 | 1986-07-30 | Glaxo Group Ltd | Chemical compounds |
GB8928208D0 (en) * | 1989-12-13 | 1990-02-14 | Glaxo Group Ltd | Medicaments |
-
1990
- 1990-12-12 GB GB909026998A patent/GB9026998D0/en active Pending
-
1991
- 1991-12-10 WO PCT/EP1991/002362 patent/WO1992010477A1/en active IP Right Grant
- 1991-12-10 AU AU90720/91A patent/AU650706B2/en not_active Expired
- 1991-12-10 RU RU93053493A patent/RU2108328C1/ru not_active IP Right Cessation
- 1991-12-10 KR KR1019930701760A patent/KR100211479B1/ko not_active IP Right Cessation
- 1991-12-10 CA CA002098302A patent/CA2098302C/en not_active Expired - Lifetime
- 1991-12-10 JP JP4501645A patent/JP2994037B2/ja not_active Expired - Lifetime
- 1991-12-10 CZ CS931140A patent/CZ281931B6/cs not_active IP Right Cessation
- 1991-12-10 YU YU191491A patent/YU48926B/sh unknown
- 1991-12-11 CN CN91107596A patent/CN1030890C/zh not_active Expired - Fee Related
- 1991-12-11 MY MYPI91002297A patent/MY109265A/en unknown
- 1991-12-11 ZA ZA919750A patent/ZA919750B/xx unknown
- 1991-12-11 NL NL9102071A patent/NL9102071A/nl not_active Application Discontinuation
- 1991-12-11 TW TW080109719A patent/TW205035B/zh not_active IP Right Cessation
- 1991-12-11 GB GB9126297A patent/GB2251614B/en not_active Revoked
- 1991-12-11 IS IS3790A patent/IS1706B/is unknown
- 1991-12-11 FR FR919115359A patent/FR2670487B1/fr not_active Expired - Lifetime
- 1991-12-11 BE BE9101129A patent/BE1005085A3/fr not_active IP Right Cessation
- 1991-12-11 IE IE431791A patent/IE62894B1/en not_active IP Right Cessation
- 1991-12-11 CH CH3647/91A patent/CH684192A5/fr not_active IP Right Cessation
- 1991-12-11 IT ITRM910922A patent/IT1252868B/it active IP Right Grant
- 1991-12-11 PT PT99757A patent/PT99757B/pt not_active IP Right Cessation
- 1991-12-11 NZ NZ240942A patent/NZ240942A/en not_active IP Right Cessation
- 1991-12-11 EG EG75391A patent/EG20219A/xx active
- 1991-12-11 IL IL10033091A patent/IL100330A/en not_active IP Right Cessation
- 1991-12-11 MX MX9102501A patent/MX9102501A/es unknown
- 1991-12-11 AP APAP/P/1991/000339A patent/AP230A/en active
- 1991-12-11 TW TW081105493A patent/TW300886B/zh active
- 1991-12-12 DK DK91311583.8T patent/DK0490689T3/da active
- 1991-12-12 DE DE69108200T patent/DE69108200T2/de not_active Expired - Lifetime
- 1991-12-12 AT AT91311583T patent/ATE119881T1/de not_active IP Right Cessation
- 1991-12-12 EP EP91311583A patent/EP0490689B1/de not_active Expired - Lifetime
- 1991-12-12 ES ES91311583T patent/ES2069836T3/es not_active Expired - Lifetime
-
1995
- 1995-02-20 CN CN95100529A patent/CN1050831C/zh not_active Expired - Fee Related
- 1995-03-16 GR GR940403944T patent/GR3015430T3/el unknown
- 1995-06-02 US US08/460,791 patent/US5554639A/en not_active Expired - Lifetime
- 1995-06-23 HU HU95P/P00422P patent/HU211937A9/hu unknown
-
1996
- 1996-05-21 US US08/651,961 patent/US5705520A/en not_active Expired - Lifetime
-
1997
- 1997-06-19 HK HK82697A patent/HK82697A/xx not_active IP Right Cessation
- 1997-12-05 CY CY200597A patent/CY2005A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE119881T1 (de) | 3-(2-(dimethylamino)ethyl>-n-methyl-1h-indol-5- methansulfonamid sulfat (2:1). | |
NO920018D0 (no) | 1,3-oksatiolannukleosidanaloger | |
DE69226449D1 (de) | 2-(2,6-difluorphenyl)-4-(2-ethoxy-4-tert-butylphenyl)-2-axazoline | |
FR2680619B1 (fr) | Predicteur d'image. | |
MA22668A1 (fr) | Procede de preparation d'oxamides . | |
NO965084D0 (no) | N-[3(3-cyanopyrazol[1,5-aÅpyrimidin-7-yl)fenylÅ-N-etyl-acetamid | |
FI912218A (fi) | Med ultraviolet straolning haerdbar klarbelaeggning. | |
SV1996000004A (es) | 2-(2-n-alcoxifenil)-purin-6-onas 9 sustituidas | |
FR2727855B1 (fr) | Implants d'extension caverneuse | |
FR2677801B3 (fr) | Nouvelle structure d'electroaimant. | |
OA09301A (fr) | "Nouvelle forme galénique orale améliorant la biodisponibilité". | |
FI923201A (fi) | 3,4-dehyropiperidinderivat | |
FR2735986B3 (fr) | Prolongateur d'haltere | |
KR910018729U (ko) | 현상기의 닥터 갭 조절장치 | |
ITGE910039V0 (it) | "boa segna-sub" | |
BR9510219A (pt) | Monômeros de ciclohexan-1-ona 3,3-(dissubstituidos) e compostos relacionados | |
ES1018426Y (es) | "muneco didactico" | |
ES1018982Y (es) | "braga-compresa" | |
ITPE910048V0 (it) | "sbossolatrice" | |
ITRE910101U1 (it) | "espositore" | |
ITPS910048V0 (it) | "sbossolatrice" | |
SE9001883D0 (sv) | Pivaasaengen "nattugglan" | |
FI924721A (fi) | 2,3-dideoxy-4-tioribonukleosider som antivirala aemnen | |
KR950022316U (ko) | 이노베이션의 ic용 튜브공급장치 | |
ITMO910077V0 (it) | "bigodino" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EELA | Cancelled due to lapse of time |